Scarica l'app Stockscreener
4.15
3.49%
-0.15
Dopo l'orario di chiusura:
4.07
-0.08
-1.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.30
Aprire:
$4.29
Volume 24 ore:
1.30M
Relative Volume:
0.88
Capitalizzazione di mercato:
$717.27M
Reddito:
-
Utile/perdita netta:
$-54.70M
Rapporto P/E:
-12.58
EPS:
-0.33
Flusso di cassa netto:
$-51.36M
1 W Prestazione:
-4.82%
1M Prestazione:
+16.25%
6M Prestazione:
+29.69%
1 anno Prestazione:
+14.17%
Intervallo 1D:
$4.14
$4.40
Intervallo di 1 settimana:
$4.14
$4.505
Portata 52W:
$1.89
$4.505
Savara Inc Stock (SVRA) Company Profile
Nome
Savara Inc
Settore
Industria
Telefono
51285113796
Indirizzo
6836 BEE CAVE ROAD, AUSTIN, TX
Confronta SVRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
4.15 | 743.26M | 0 | -54.70M | -51.36M | -0.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-08-15 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2025-05-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-12-20 | Iniziato | Wells Fargo | Overweight |
| 2024-11-13 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-02-15 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-11-07 | Iniziato | Guggenheim | Buy |
| 2023-05-16 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-03-31 | Downgrade | Jefferies | Buy → Hold |
| 2021-03-16 | Iniziato | Piper Sandler | Overweight |
| 2021-03-15 | Iniziato | Oppenheimer | Outperform |
| 2019-06-13 | Reiterato | H.C. Wainwright | Buy |
| 2019-06-13 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | Ripresa | ROTH Capital | Neutral |
| 2018-01-03 | Iniziato | Ladenburg Thalmann | Buy |
| 2017-09-27 | Ripresa | ROTH Capital | Buy |
| 2017-09-22 | Iniziato | Jefferies | Buy |
| 2017-09-11 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Savara Inc Borsa (SVRA) Ultime notizie
SVRA DEADLINE: ROSEN, HIGHLY RANKED INVESTOR RIGHTS COUNSEL, Encourages Savara Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 7 Deadline in Securities Class Action– SVRA - GlobeNewswire Inc.
How strong dollar benefits Savara Inc. (YB4P) stockStop Loss & Capital Efficient Trade Techniques - newser.com
Investors SueWallSt Over Savara Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
Savara completes $149.5 million public offering of common stock By Investing.com - Investing.com South Africa
Savara Closes $149.5 Million Public Offering - MarketScreener
Savara completes $149.5 million public offering of common stock - Investing.com
Savara (NASDAQ: SVRA) closes $149.5M offering priced at $4.20; option exercised - Stock Titan
Savara Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $149.5M - The Joplin Globe
Investors in Savara Inc. Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss ... - Bluefield Daily Telegraph
Investors in Savara Inc. Should Contact Levi & Korsinsky Before November 7, 2025 to Discuss Your Rights – SVRA - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - Newsfile
SAVARA CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Savara Investors to ... - Bluefield Daily Telegraph
SAVARA CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, - GlobeNewswire
Is Savara Inc. (YB4P) stock in buy zone after pullbackStop Loss & Verified Short-Term Trading Plans - newser.com
Emerald Mutual Fund Advisers Trust Grows Position in Savara Inc. $SVRA - MarketBeat
Savara Inc. $SVRA Shares Purchased by Emerald Advisers LLC - MarketBeat
Pattern recognition hints at Savara Inc. upsideJuly 2025 Review & Risk Controlled Swing Trade Alerts - newser.com
Visual analytics tools that track Savara Inc. performanceJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com
Chart overlay techniques for tracking Savara Inc.Market Performance Recap & Stock Timing and Entry Methods - newser.com
RTW Biotech Opportunities says Savara announces $75 million funding agreement with co - MarketScreener
Latham & Watkins Advises RTW Investments in US$75 Million Royalty Funding Agreement With Savara - Latham & Watkins LLP
Will Savara Inc. (YB4P) stock boost dividends further2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com
What Does Wall Street Think About Savara Inc. (SVRA)? - MSN
SVRA FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Savara Inc. Investors to ... - Caledonian Record
Applying sector rotation models to Savara Inc.Quarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Savara Announces $130 Million Public Offering - TipRanks
SVRA sets underwritten deal; 30-day option for 4,642,857 shares - Stock Titan
Savara Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm ... - Bluefield Daily Telegraph
Savara Inc. Sued for Securities Law Violations – Investors - GlobeNewswire
SVRA Deadline: Rosen Law Firm Urges Savara Inc. (NASDAQ: SVRA) Stockholders to Contact the Firm for Information About Their Rights - The AI Journal
Investors SueWallSt as Savara Inc. Faces Securities Fraud Allegations - Nasdaq
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - FinancialContent
Savara (NASDAQ:SVRA) Hits New 12-Month HighHere's Why - MarketBeat
Pomerantz Law Firm Announces the Filing of a Class Action Against Savara Inc. and Certain Officers – SVRA - FinancialContent
Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants - BioSpace
Savara (SVRA) Launches $130M Public Offering - GuruFocus
Savara (Nasdaq: SVRA) prices public offering: 23.8M shares, 7.14M pre-funded warrants - Stock Titan
Savara announces pricing of public offering at $4.20 per share - MarketScreener
Savara announces $75M Royalty Funding Agreement with RTW to Support the Potential Launch of MOLBREEVI* in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) - BioSpace
Savara Inc. (NASDAQ: SVRA) Investor Alert: Deadline in Lawsuit on November 7, 2025 - openPR.com
Savara Announces $75M Royalty Funding Agreement - TipRanks
Savara Inc. (SVRA) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Savara Announces Proposed Public Offering - MarketScreener
Savara (NASDAQ: SVRA) proposes public offering with pre-funded warrants and 15% option - Stock Titan
Savara (NASDAQ: SVRA) secures $75M royalty funding for MOLBREEVI, subject to FDA approval - Stock Titan
SVRA secures $75M contingent royalty sale; royalties up to 9.5% - Stock Titan
Savara Inc. (SVRA) To Present Molgramostim Data in the Fight Against Infections - Insider Monkey
SVRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Savara Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
Will Savara Inc. stock rally after Fed decisionsJuly 2025 Reactions & AI Powered Market Entry Ideas - newser.com
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Savara Inc. - Your Wyoming Link
Savara Inc Azioni (SVRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):